Accès ouvert
2026
article
OpenAlex
Lauren Nassour, Mayada Ahmed, Shane T. Rich-New, Taylor L. Schanel et autres
During glioblastoma (GBM) progression, therapeutic resistance is influenced by a heterogeneous network of tumor- and tumor-promoting subpopulations within the tumor microenvironment. Therapeutic interventions against tumor cells, such as chemoradiotherapy, can further induce adaptive defense mechanisms mediated by sophisticated intercellular communication and aberrant …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Patrick N. Song, Chloe T. DeMellier, Shannon E. Lynch, Carlos A. Gallegos et autres
PURPOSE: PET imaging targeting immune cells can be used to dynamically monitor intratumoral immune modulation in tissues. Radiation therapy is known to alter the tumor immune microenvironment; therefore, this study demonstrates how CD8 immunoPET imaging can optimize combination immunotherapy and radiation therapy …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
E. Kudaravalli, Amr Elkholy, Mostafa Mohamed, Hasan Alrefai et autres
Abstract Glioblastoma (GBM) is the most aggressive and common malignant brain tumor in adults, with a median survival of just 14.6 months. Standard treatment, comprising maximal surgical resection followed by radiation and temozolomide, offers limited long-term benefit, highlighting the urgent need for …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
S Dunlap, Caitlin A. Harvey, Christopher D. Willey, Ahn Erin
Abstract Introduction: Glioblastoma (GBM) is the most common malignant brain tumor in adults, and resistance to radiation therapy remains a major therapeutic obstacle. Although genetic alterations contribute to GBM progression, they do not fully explain the emergence of radiation resistance, suggesting contributions …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Amr Elkholy, E. Kudaravalli, Mostafa Mohamed, Hasan Alrefai et autres
Abstract Glioblastoma (GBM) is the most aggressive primary brain tumor. Despite advances in immunotherapy for other solid tumors, T-cell checkpoint blockades have failed to improve overall survival in GBM patients, largely due to low T-cell infiltration. In contrast, tumor-associated macrophages (TAMs) comprise …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Taylor Lynn Schanel, Amber Jones, Rhea Pandit, Johsua C. Anderson et autres
Abstract Glioblastoma (GBM) is the most common primary brain tumor in adults with a median survival of less than 15 months with maximal safe surgical resection, radiation, and the chemotherapy temozolomide. Addition of Tumor Treating Fields (TTFields), or alternating electromagnet fields therapy, …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Kenneth H. Hu, Pratish Shah, M. Connie Nguyen, Cornelia McCluskey et autres
Abstract Purpose This study evaluated the safety and effectiveness of an intraoral light-emitting diode (LED)-based photobiomodulation (PBM) device to reduce the incidence and severity of oral mucositis (OM) from intensity modulated radiation therapy (IMRT) for head and neck cancer (HNC). Methods This …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Christopher D. Willey, Lauren Nassour, Mayada Ahmed, Shane T. Rich-New et autres
us
(code pays fourni par la source)
Accès ouvert
2026
data-paper
OpenAlex
Daniel Bottomly, Christopher G. Suciu, Benjamin Cordier, Nathaniel Evans et autres
Biomedical machine learning (ML) models raise critical concerns about embedded assumptions influencing clinical decision-making, necessitating robust documentation frameworks for datasets that are shared via external repositories. Fairness-aware algorithm effectiveness hinges on users' prior awareness of specific issues in the data - information …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Barbara A. Murphy, Derek K. Smith, Cristina M. Kline‐Quiroz, K. S. Jensen et autres
BACKGROUND: Two-month outcomes of advanced pneumatic compression device (APCD) and usual care (UC) in Head and Neck Cancer survivors with previously untreated lymphedema were compared. METHODS: Participants in this multisite, randomized clinical trial were randomized to APCD or UC. The primary endpoint …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Andrew B. Bonner, Herbert Chen, Sharon A. Spencer, Christopher D. Willey et autres
BACKGROUND: Anaplastic thyroid cancer is an aggressive malignancy, for which prompt treatment is necessary. Surgical resection is the recommended initial treatment for resectable cases and most patients require postoperative radiation therapy (PORT). NCCN Guidelines state that adjuvant radiation should ideally begin 2–3 …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yogesh Kumar, H. H. Chang, Udbhav S Ram, Gaurav N. Rathi et autres
Background: Brain metastases (BMs) patients often receive multiple courses of radiotherapy (RT). Comparing follow-up imaging with RT plans is time-intensive and currently not possible in picture archiving and communication system (PACS). In this study, we aim to develop an automated tool to …
us
(code pays fourni par la source)